Ben joined GTCR in 2008 and is currently a Managing Director of the firm. Prior to joining GTCR, he worked as a Venture Capitalist at Alta Partners, as well as an Investment Banking Associate at JMP Securities and an Analyst in the Mergers & Acquisitions group at J.P. Morgan (formerly Hambrecht & Quist). He holds an MBA from the Wharton School at the University of Pennsylvania and a BA in history magna cum laude from Colgate University. Ben also holds a master’s degree in biotechnology from the School of Applied Sciences & Engineering at the University of Pennsylvania.

He is currently a Director of Albany Molecular Research, Cole Parmer, Corza Health, Maravai LifeSciences and TerSera. Ben was previously a Director of past GTCR investments including Actient Pharmaceuticals, Cord Blood Registry, Crealta Pharmaceuticals, Devicor Medical Products, GeneraMedix, Sterigenics and XIFIN. In addition, Ben was involved in transactions with past GTCR investments ATI Physical Therapy and Graceway Pharmaceuticals.

Lenard is responsible for leading Edison investments in companies primarily located in the mid-Atlantic area. Lenard co-leads healthcare IT investments and leads Edison’s security practice. Lenard is active in the mid-Atlantic venture community serving as a board member for the Maryland Venture Fund and Greater Baltimore Technology Council.

Lenard began his career at IBM where he worked as a Financial Analyst for IBM Global Services. His main responsibilities were overseeing a budget of $80 million and partnering with international locations to decrease the project costs of IBM Global Services West. Later, Lenard worked for Princeton eCom—an online bill payment company—where, as Manager of B2C Implementations; he oversaw one of the largest joint ventures in the company’s history. Lenard later led B2C Product Development at Princeton eCom prior to earning his MBA. Lenard also worked in healthcare investment banking for Wachovia Securities.

Lisa Mazur advises health care providers and technology companies on a variety of legal, regulatory and compliance matters.

Lisa advises a variety of health care providers and technology companies involved in “digital health” – the intersection of health software applications, analytical tools, medical technology and electronic data assets enabled by the Internet and mobile devices – on the applicable legal and regulatory infrastructure, with a particular focus on telehealth, telemedicine, mobile health and consumer wellness programs. Lisa assists her clients to identify and understand the relevant legal issues, and develop and implement practical, forward-thinking compliance and revenue solutions and strategies that meet the complex and still-evolving digital health regulatory landscape.

Jeff Rhodes is a Partner of TPG in the San Francisco office, where he co-leads the healthcare group and the firm’s investment activities in the healthcare services, pharmaceutical, and medical device sectors. Jeff serves on the boards of BVI, Immucor, Kelsey Seybold Clinic, Kindred at Home, Kindred Healthcare, Lifestance and WellSky. He previously served on the Boards of Biomet, EnvisionRx, IMS Health, Par Pharmaceutical Companies, Surgical Care Affiliates, Zimmer Biomet and as a founding Board member of the Healthcare Private Equity Association. He also serves on the Leadership Council of The Nature Conservancy California, the Governing Council of The Wilderness Society, and is Vice Chairman of the Northstar Teams Foundation (Ski and Snowboard). Jeff received his MBA from the Harvard Business School and earned his BA from Williams College.